Stefan Gruenwald


Founder of Corporate Governance Partners (, co-founder, seed investor and Chief Technology Officer of Diagnomics (, and Managing Director at Genautica (, co-founder and Head of SAB at DNA SEQ Alliance ( with over 25 years experience in the Biotech Industry in San Diego, CA. Was the VP or R&D at PharMingen (91-97) and the VP R&D at Becton Dickinson (97-00). Founder of Orbigen (00-04). Involved in several merger / acquisitions in the $200+ MM range.

Academic degree: MD / PhD (summa cum laude, Best-Thesis-Of-The-Year Award). Involved in technology scouting and evaluation for over 15 years.

Initiator and curator of popular Science Newsletter ( with over 800,000 reads. Fluent in English and German. Studied Human Medicine, Biology and Physics at the Johann-Wolfgang-Goethe University in Frankfurt / Germany. Broad scientific knowledge in many disciplines, including Biotechnology and Nanotechnology.

Specialties: Biotechnology management, start-up company management, Fortune 100 company management, mergers and aquisitions, Venture Capital, Private Equity, Funds of Funds, International contacts, Russia, China. Nanotechnology Investment. Computer skills: Assembly language, HTML5, CSS3, Javascript, jQuery, PHP, MySQL, UNIX and python.

You can email me (sgruenwald at and find me on LinkedIn (sgruenwald), Twitter (@sgruenwald), Pinterest (genautica), Rebelmouse (sgruenwald) and SKYPE (esmestefan).